Indegene Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | May 6, 2024 to May 8, 2024 |
| Listing Date | - |
| Face Value | ₹ 2 per share |
| Price Band | ₹ 430 to ₹ 452 per share |
| Lot Size | 33 Shares |
| Total Issue Size | 4,07,46,891 shares (aggregating up to ₹ 1,841.76 Cr) |
| Fresh Issue | 1,68,14,159 shares (aggregating up to ₹ 760.00 Cr) |
| Offer for Sale | 2,39,32,732 shares of ₹2 (aggregating up to ₹ 1,081.76 Cr) |
| Employee Discount | Rs 30 per share |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 22,24,35,091 |
| Share holding post issue | 23,92,49,250 |
About Indegene Limited IPO
Indegene Ltd. (IL) is providing digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner. Indegene IPO is a book built issue of Rs 1,841.76 crores.
The issue is a combination of fresh issue of 1.68 crore shares aggregating to Rs 760.00 crores and offer for sale of 2.39 crore shares aggregating to Rs 1,081.76 crores. Indegene IPO price band is set at ₹430 to ₹452 per share. The minimum lot size for an application is 33 Shares. Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory And Securities (India) Pvt Ltd are the book running lead managers of the Indegene IPO, while Link Intime India Private Ltd is the registrar for the issue.
Objectives of Indegene IPO
The Company proposes to utilise the Net Proceeds towards funding the following objectives:-
- 1. Repayment/prepayment of indebtedness of one of the Material Subsidiaries, ILSL Holdings.
- 2. Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene.
- 3. General corporate purposes and inorganic growth.
The company has a unique business model and enjoys virtual monopoly in its business that generates over 98% global revenue. It marked steady growth in its top and bottom lines for the reported periods, and the segment is poised for bright prospects ahead. Based on FY24 annualized earnings, the issue appears fully priced, but considering its niche play, it is reasonably priced leaving something on table for one and all. Investors may lap up this IPO for the medium to long term rewards.
Indegene Limited IPO Financial Information
Latest Revenue
1,969.75
₹ Crore
Profit After Tax
241.90
₹ Crore
Net Worth
1,327.00
₹ Crore
Total Borrowing
399.33
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing | ||||
|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 2023 | 2,518.15 | 1,969.75 | 241.90 | 1,327.00 | 399.33 | ||||
| 31 Mar 2023 | 2,203.87 | 2,364.10 | 266.10 | 1,063.72 | 394.34 | ||||
| 31 Mar 2022 | 1,353.47 | 1,690.50 | 162.82 | 763.90 | 18.24 | ||||
| 31 Mar 2021 | 596.04 | 996.92 | 149.41 | 324.51 | 24.76 | ||||
| Amount in ₹ Crore | |||||||||
Indegene Limited Key Performance Indicator
| KPI | Values |
|---|---|
| Debt/Equity | 0.3 |
| RoNW | 18.23% |
| P/BV | 7.55 |
| PAT Margin (%) | 12.62 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 11.96 | 13.48 |
| P/E (x) | 37.78 | 33.53 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Indegene Limited IPO Timeline
| IPO Open Date | Monday, May 6, 2024 |
| IPO Close Date | Wednesday, May 8, 2024 |
| Basis of Allotment | Thursday, May 9, 2024 |
| Initiation of Refunds | Friday, May 10, 2024 |
| Credit of Shares to Demat | Friday, May 10, 2024 |
| Listing Date | Monday, May 13, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on May 8, 2024 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,916 |
| Retail (Max) | 13 | 429 | ₹193,908 |
| S-HNI (Min) | 14 | 462 | ₹208,824 |
| S-HNI (Max) | 67 | 2,211 | ₹999,372 |
| B-HNI (Min) | 68 | 2,244 | ₹1,014,288 |